Exact Mass: 450.00412239999997

Exact Mass Matches: 450.00412239999997

Found 46 metabolites which its exact mass value is equals to given mass value 450.00412239999997, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ferene

5-[3-(Pyridin-2-yl)-6-(5-sulphofuran-2-yl)-1,2,4-triazin-5-yl]furan-2-sulphonic acid

C16H10N4O8S2 (449.994006)

Methyl-3,5-dichloro-4,4-di-O-methylatromentate

C21H16Cl2O7 (450.0273046)

CAY10595

5-chloro-1-[5-chloro-2-fluorophenyl)methyl]-2,2,5-trioxo-spiro[3H-indole-3,3pyrrolidine]-1(2H)-acetic acid

C20H13Cl2FN2O5 (450.018552)

sodium 2-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethanesulphonate

C17H16ClN2NaO5S2 (450.00868360000004)

perfluoro-1,3,5-trimethylcyclohexane

C9F18 (449.97125759999994)

1H,1H-Perfluorononan-1-ol

C9H3F17O (449.9912432)

1H,1H-Perfluoro-3,5,5-trimethyl-1-hexanol

C9H3F17O (449.9912432)

Magnesium citrate

C12H10Mg3O14 (449.96220600000004)

B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CB - Salt solutions A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AD - Osmotically acting laxatives A - Alimentary tract and metabolism > A12 - Mineral supplements > A12C - Other mineral supplements > A12CC - Magnesium D005765 - Gastrointestinal Agents > D002400 - Cathartics

1-chloro-3,5-diparanitrobenzoyl-2-deoxy-d-ribose

C19H15ClN2O9 (450.046605)

1-(3,5-DIMETHYLPHENYL)-2-METHYL-1H-IMIDAZOLE

C19H20Br2N2O (449.99422699999997)

Hexafluoropropene trimer

C9F18 (449.97125759999994)

4-methyl-2-nitrobenzenediazonium,naphthalene-1,5-disulfonate

C17H12N3O8S2 (450.00658119999997)

Ytterbium(3+) nitrate hydrate (1:3:5)

H10N3O14Yb (449.955151)

[3-[(4,8-diamino-6-bromo-1,5-dioxonaphthalen-2-yl)amino]phenyl]-trimethylazanium,chloride

C19H20BrClN4O2 (450.045807)

bromopentane

C15H33Br3 (450.0132198)

(S)-(-)-3,3-Dibromo-5,5,6,6,7,7,8,8-octahydro-1,1-bi-2,2-naphthalenediol

C20H20Br2O2 (449.98299399999996)

Aluminum phenylphosphinate

C18H18AlO6P3 (450.01316280000003)

N-(5-Bromo-2-pyridinyl)-2-[(4-cyanobenzoyl)amino]-5-methoxybenzamide

C21H15BrN4O3 (450.032746)

2-[(2,5-dichlorophenyl)azo]-N-(6-ethoxy-2-benzothiazolyl)-3-oxo-Butanamide

C19H16Cl2N4O3S (450.03201260000003)

2-Mercaptobenzothazolyl (Z)-2-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonylmethoxyimino)acetate

C18H18N4O4S3 (450.04901480000007)

Hexanitro-1,2-diphenylethylene

C14H6N6O12 (450.0043716)

2,2-BIS(TRIFLUOROMETHANESULFONYLOXY)-1,1-BIPHENYL

C14H8F6O6S2 (449.96664999999996)

Ibrolipim

C19H20BrN2O4P (450.03439900000006)

D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D008082 - Lipotropic Agents C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D020536 - Enzyme Activators > D058867 - Lipoprotein Lipase Activators D009676 - Noxae > D000963 - Antimetabolites Ibrolipim (NO-1886) is an orally active lipoprotein lipase (LPL)-promoting agent. Ibrolipim decreases plasma triglycerides, increases high-density lipoprotein cholesterol levels. Ibrolipim has renoprotective and hypolipidemic effects[1][2][3].